NCT02484417View on ClinicalTrials.gov

Respiratory Syncytial Virus Human Challenge in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 21, 2015

Primary Completion Date

August 10, 2016

Study Completion Date

August 10, 2016

Conditions
Upper Respiratory Tract Infection
Interventions
BIOLOGICAL

RSV A2

Intranasal inoculation of healthy volunteers with 10\^5 or 10\^6.3 plaque forming units (PFU) of RSV A2.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT02484417 - Respiratory Syncytial Virus Human Challenge in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter